Serum markers in prostate cancer detection.
Author
Summary, in English
Prostate-specific antigen (PSA) testing provides significant benefits by reducing prostate cancer mortality, but also leads to important harms by detecting clinically insignificant cancers. Hence, there are urgent needs for complementary tools for middle-aged men with modest PSA elevations in blood. This review includes research on prostate cancer biomarkers in blood published from March 2013 through August 2014.
Department/s
- Urological cancer, Malmö
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Clinical Chemistry, Malmö
- EpiHealth: Epidemiology for Health
Publishing year
2015
Language
English
Pages
59-64
Publication/Series
Current Opinion in Urology
Volume
25
Issue
1
Links
Document type
Journal article
Publisher
Lippincott Williams & Wilkins
Topic
- Cancer and Oncology
Status
Published
Research group
- Urological cancer, Malmö
- Clinical Chemistry, Malmö
ISBN/ISSN/Other
- ISSN: 0963-0643